| 标题 |
Sovleplenib (HMPL-523), a novel Syk inhibitor, for patients with primary immune thrombocytopenia in China: a randomised, double-blind, placebo-controlled, phase 1b/2 study |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Haematology 作者:Xiaofan Liu; Hu Zhou; Yu Hu; Jie Yin; Junmin Li; et al 出版日期:2023-04-05 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)